Supplementation with vitamin E or selenium does not reduce risk of prostate cancer

In perhaps the largest cancer chemoprevention trial ever conducted, researchers have found that supplementation with vitamin E or selenium, alone or in combination, was not associated with a lower risk of prostate cancer or other cancers. This study, along with another cancer prevention study, will be published in the 7 January issue of JAMA, and both reports are being released early online because of public health implications...

Read the whole article on

More from